Skip to content
Review Open access

Inflammatory cell death in cancer: linking pyroptosis, necroptosis, ferroptosis, PANoptosis, and antitumor immunity

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 186 references
Medicine

TL;DR

It is proposed that future cancer therapy should move beyond simply inducing tumor cell death toward designing immune-productive death programs that are spatially controlled, cell-type selective, and rationally synchronized with immunotherapy.

Abstract

Inflammatory cell death has emerged as a critical interface between cancer therapy and antitumor immunity. Unlike relatively non-inflammatory cell death, pyroptosis, necroptosis, ferroptosis, and PANoptosis can generate or release damage-associated molecular patterns (DAMPs), tumor antigens, inflammatory cytokines, oxidized lipids, and nucleic acid ligands that reshape the tumor microenvironment. These death programs link therapeutic stress to dendritic cell activation, antigen cross-presentation, type I interferon signaling, cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling, and cytotoxic T-cell responses. However, their immune consequences are highly context dependent. Preclinical studies suggest that selected inflammatory cell death pathways may improve responses to immune checkpoint blockade under defined experimental conditions; however, these effects vary with tumor type, cellular context, and treatment modality, and their clinical relevance remains to be established. Conversely, ferroptosis or PANoptosis in suppressive myeloid cells can reinforce immune evasion. This review summarizes recent experimental advances connecting inflammatory cell death with tumor immunity, focusing on molecular executors, immune mediators, therapeutic opportunities, biomarkers, and translational challenges. We propose that future cancer therapy should move beyond simply inducing tumor cell death toward designing immune-productive death programs that are spatially controlled, cell-type selective, and rationally synchronized with immunotherapy.

Read PDF

Similar papers

Review Open access Nov 2026

Rewiring immune cell death in ovarian cancer: pyroptosis, apoptosis, and the immunosuppressive microenvironment

Ovarian cancer remains the most lethal gynecological malignancy, in large part because of its highly immunosuppressive tumor microenvironment (TME) and limited responsiveness to current immunotherapies. Emerging evidence indicates that programmed cell death of immune cells is an important determinant of immune dysfunct...

Hong-Mei Zhu, Lu-Yue Kang, Liang Shen · 0 citations
Review Open access Oct 2026

Ferroptosis in the tumor immune microenvironment: from danger signals to immune reprogramming

Immune-checkpoint blockade has changed cancer therapy, yet durable responses remain limited by immune exclusion, myeloid suppression and metabolic adaptation within the tumor immune microenvironment. Ferroptosis, an iron-dependent form of lipid-peroxidation-driven regulated cell death, offers a mechanistic bridge betwe...

Qing-Miao Shi, Bing-Qian Tan, Hui-Wu Xing · 0 citations
Review Open access Oct 2026

Regulated Tumor-cell Death in Chemoimmunotherapy: Mechanisms, Biomarkers, and Clinical Translation

Background/Aim: Immune-checkpoint blockade is most effective when tumor antigens are visible, innate sensing is intact, and effector lymphocytes can enter the tumor microenvironment. This narrative review evaluates regulated tumor-cell death as the mechanistic interface between chemotherapy and checkpoint inhibition. M...

Mariangela Garofalo, L. Kuryk · 0 citations
Open access Oct 2026

Beyond apoptosis: the emerging landscape of non-canonical cell death in hepatobiliary malignancies and immunotherapeutic strategies

Abstract Non-apoptotic cell death modalities shape the tumor immune microenvironment and treatment outcomes in hepatobiliary cancers. Ferroptosis could directly kill cancer cells and enhance antitumor immunity and immunotherapy efficacy, but it may also promote immunosuppression in some contexts. Cuproptosis could elim...

Gui-Feng Sun, Pei Zhou · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.